43 results
8-K
EX-99.1
FBIO
Fortress Biotech Inc
15 May 24
Fortress Biotech Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
4:20pm
. The study will also evaluate whether this intervention might reduce chronic inflammation and immune activation, as compared to placebo, and thus, potentially
8-K
EX-99.1
FBIO
Fortress Biotech Inc
15 May 23
Fortress Biotech Reports First Quarter 2023 Financial Results and Recent Corporate Highlights
5:05pm
lymphomas (“B-NHL”) and chronic lymphocytic leukemia (“CLL”), throughout the year. Dotinurad for the treatment of gout and Triplex for the treatment
8-K
EX-99.1
69ciqtva xn
30 Mar 23
Fortress Biotech Reports Record 2022 Financial Results and Recent Corporate Highlights
5:28pm
8-K
EX-99.1
riyynh9eq1u8ls
14 Nov 22
Fortress Biotech Reports Third Quarter 2022 Financial Results and Recent Corporate Highlights
5:02pm
8-K
EX-99.1
a4kh hafxh4ycb3fm83z
11 Aug 22
Fortress Biotech Reports Second Quarter 2022 Financial Results and Recent Corporate Highlights
4:46pm
8-K
EX-99.1
q8z5wsxn5
12 May 22
Fortress Biotech Reports First Quarter 2022 Financial Results and Recent Corporate Highlights
4:16pm
8-K
EX-99.1
1bw0abzlu nw
28 Mar 22
Fortress Biotech Reports Record 2021 Financial Results and Recent Corporate Highlights
8:16am
8-K
EX-99.1
7g6mhiu3r9
15 Nov 21
Fortress Biotech Reports Record Third Quarter 2021 Financial Results and Recent Corporate Highlights
4:15pm
8-K
EX-99.1
30yvst774bah9t9f7
16 Aug 21
Fortress Biotech Reports Record Second Quarter 2021 Financial Results and Recent Corporate Highlights
4:08pm
8-K
EX-99.1
b5kmgd p24x
17 May 21
Fortress Biotech Reports First Quarter 2021 Financial Results and Recent Corporate Highlights
4:21pm